Metformin Therapy and Risk of Cancer in Patients with Type 2 Diabetes: Systematic Review

• Monica Franciosi ,

  * E-mail: franciosi@negrisud.it

  Affiliation Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S. Maria Imbaro (CH), Chieti, Italy

  ⨯
• Giuseppe Lucisano,

  Affiliation Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S. Maria Imbaro (CH), Chieti, Italy

  ⨯
• Emanuela Lapice,

  Affiliation Department of Clinical and Experimental Medicine, University of Naples Federico II, Naples, Italy

  ⨯
• Giovanni F. M. Strippoli,

  Affiliations Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S. Maria Imbaro (CH), Chieti, Italy, Diaverum Medical Scientific Office, Lund, Sweden, School of Public Health, University of Sydney, Darlington, Australia, University of Bari, Bari, Italy

  ⨯
• Fabio Pellegrini,

  Affiliation Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S. Maria Imbaro (CH), Chieti, Italy

  ⨯
• Antonio Nicolucci

  Affiliation Department of Clinical Pharmacology and Epidemiology, Consorzio Mario Negri Sud, S. Maria Imbaro (CH), Chieti, Italy

  ⨯